Literature DB >> 520397

Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.

G Nyberg, A Vedin, C Wilhelmsson.   

Abstract

The influence of intravenous labetalol and propranolol on the blood pressure response to isometric and dynamic exercise was examined in a double blind study in eight, young, normotensive volunteers. Effects were recorded after propranolol 7.5, 15 and 30 mg i. v., and after labetalol 30, 60 and 120 mg i. v. In control experiments saline was administered. Mean blood pressure rose with successive handgrip tests following saline and propranolol, but not after labetalol, and the difference was significant. The total dose of each drug produced the same reduction in heart rate during sub-maximal bicycle exercise. The exercise-induced systolic blood pressure response did not differ between the drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520397     DOI: 10.1007/BF00605625

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Indirect blood pressure and heart rate measured quickly without observer bias using a semi-automatic machine (auto-manometer)--response to isometric exercise in normal healthy males and its modification by beta-adrenoceptor blockade.

Authors:  G Nyberg
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

2.  Muscle metabolism during isometric exercise performed at constant force.

Authors:  B Ahlborg; J Bergström; L G Ekelund; G Guarnieri; R C Harris; E Hultman; L O Nordesjö
Journal:  J Appl Physiol       Date:  1972-08       Impact factor: 3.531

3.  Labetalol in long-term treatment of hypertension.

Authors:  B N Prichard; A J Boakes
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  Constituents of human muscle in isometric fatigue.

Authors:  J Karlsson; C F Funderburk; B Essen; A R Lind
Journal:  J Appl Physiol       Date:  1975-02       Impact factor: 3.531

Review 5.  A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.

Authors:  R T Brittain; G P Levy
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

Review 6.  Pharmacological effects of labetalol in man.

Authors:  D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

7.  Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.

Authors:  I K Bailey; S D Anderson; P J Rozea; L Bernstein; G Nyberg; P I Korner
Journal:  Am Heart J       Date:  1976-10       Impact factor: 4.749

8.  Metabolism of labetalol by animals and man.

Authors:  L E Martin; R Hopkins; R Bland
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

9.  Labetalol in resistant hypertension.

Authors:  H J Dargie; C T Dollery; J Daniel
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

10.  Effect of long-term anti-hypertensive beta-receptor-blocking treatment on haemodynamic and metabolic responses to prolonged exercise in man.

Authors:  M Frisk-Holmberg; A Juhlin-Dannfeldt; L Jorfeldt; H Aström
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12
View more
  2 in total

1.  Are blood pressure surges associated with sympathetic stimulation aggravated by beta-adrenoceptor antagonist treatment?

Authors:  C R Kumana
Journal:  Postgrad Med J       Date:  1986-08       Impact factor: 2.401

Review 2.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.